Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.

Item

http://www.wikidata.org/entity/Q49082801

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@en

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@nl

type

Item

label

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@en

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@nl

prefLabel

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@en

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@nl

P1476

Overexpression of ANCCA/ATAD2 ...... rogression and poor prognosis.

@en

P2093

Fanling Meng

http://www.w3.org/2001/XMLSchema#string

Pan Shang

http://www.w3.org/2001/XMLSchema#string

Xiuwei Chen

http://www.w3.org/2001/XMLSchema#string

Yunduo Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers

Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.

ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.

Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

Integrated genomic and epigenomic analysis of breast cancer brain metastasis

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.

P2888

s13277-015-3089-8

P304

4479-4485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3089-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048972793

http://www.w3.org/2001/XMLSchema#string

P698

25934333

http://www.w3.org/2001/XMLSchema#string

P921

overexpression